Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13020)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YC, Xu Z, Zhang TF, Wang YL. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World J Gastroenterol 2015; 21(34): 9853-9862 [PMID: 26379392 DOI: 10.3748/wjg.v21.i34.9853] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i34/9853.htm |
| Number | Citing Articles |
| 1 |
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Tsutomu Kawaguchi, Shoji Hirajima, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Moriumura, Hisashi Ikoma, Kazuma Okamoto, Hiroki Taniguchi, Yoshito Itoh, Eigo Otsuji. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Oncotarget 2016; 7(33): 53820 doi: 10.18632/oncotarget.10781
|
| 2 |
Chiara Mazziotta, Carmen Lanzillotti, Maria Rosa Iaquinta, Francesca Taraballi, Elena Torreggiani, John Charles Rotondo, Lucia Otòn-Gonzalez, Elisa Mazzoni, Francesca Frontini, Ilaria Bononi, Monica De Mattei, Mauro Tognon, Fernanda Martini. MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells. International Journal of Molecular Sciences 2021; 22(5): 2362 doi: 10.3390/ijms22052362
|
| 3 |
Zheng‐Yang Wang, Zhu Zhu, Hua‐Fei Wang, Bo Qin, Jing Liu, Xiao‐Han Yao, Wen‐Cai Li, Kui‐Sheng Chen. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR‐140‐5p. Journal of Cellular Physiology 2019; 234(10): 17775 doi: 10.1002/jcp.28403
|
| 4 |
Mu-Sheng Zeng. The Long and Short Non-coding RNAs in Cancer Biology. Advances in Experimental Medicine and Biology 2016; 927: 391 doi: 10.1007/978-981-10-1498-7_15
|
| 5 |
Baofei Sun, Junchao Xue, Jun Li, Fei Luo, Xiong Chen, Yonglian Liu, Qingling Wang, Caihua Qi, Zhonglan Zou, Aihua Zhang, Qizhan Liu. Circulating miRNAs and their target genes associated with arsenism caused by coal-burning. Toxicology Research 2017; 6(2): 162 doi: 10.1039/C6TX00428H
|
| 6 |
Yan Jiao, Ping Xu, Honglin Shi, Dexi Chen, Hongbo Shi. Advances on liver cell‐derived exosomes in liver diseases. Journal of Cellular and Molecular Medicine 2021; 25(1): 15 doi: 10.1111/jcmm.16123
|
| 7 |
Haixin Yu, Zhong Guan, Katarina Cuk, Hermann Brenner, Yan Zhang. Circulating microRNA biomarkers for lung cancer detection in Western populations. Cancer Medicine 2018; 7(10): 4849 doi: 10.1002/cam4.1782
|
| 8 |
Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya. Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients. Oncotarget 2022; 13(1): 1341 doi: 10.18632/oncotarget.28327
|
| 9 |
Shaofeng Wei, Junchao Xue, Baofei Sun, Zhonglan Zou, Chao Chen, Qizhan Liu, Aihua Zhang. miR-145 via targeting ERCC2 is involved in arsenite-induced DNA damage in human hepatic cells. Toxicology Letters 2018; 295: 220 doi: 10.1016/j.toxlet.2018.04.028
|
| 10 |
Weronika Zofia Świtlik, Anna Bielecka-Kowalska, Michał Seweryn Karbownik, Radzisław Kordek, Maciej Jabłkowski, Janusz Szemraj. Forms of Diagnostic Material As Sources of Mirna Biomarkers in Hepatocellular Carcinoma: A Preliminary Study. Biomarkers in Medicine 2019; 13(7): 523 doi: 10.2217/bmm-2018-0485
|
| 11 |
Xiao-Ying Huang, Chun-Ying Luo, Xue-Ming Wu, Jin-Guang Yao, Chao Wang, Bing-Chen Huang, Jun Lu, Xing-Zhizi Wang, Tian-Qi Zhang, Qiang Xia, Xi-Dai Long. Aflatoxin-Control, Analysis, Detection and Health Risks. 2017; doi: 10.5772/intechopen.68419
|
| 12 |
Nicholas Latchana, Kelly Regan, John Harrison Howard, Jennifer H. Aldrink, Mark A. Ranalli, Sara B. Peters, Xiaoli Zhang, Alejandro Gru, Philip R.O. Payne, Lorena P. Suarez-Kelly, William E. Carson. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors. Journal of Surgical Research 2016; 205(2): 350 doi: 10.1016/j.jss.2016.06.085
|
| 13 |
Jin-Cui Yang, Jun-Jie Hu, Yi-Xin Li, Wei Luo, Jin-Zhou Liu, Da-Wei Ye. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.781820
|
| 14 |
Zeinab Ahsani, Samira Mohammadi-Yeganeh, Vahid Kia, Hamzeh Karimkhanloo, Nosratollah Zarghami, Mahdi Paryan. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2017; 181(3): 884 doi: 10.1007/s12010-016-2256-8
|
| 15 |
Juliane Liese, Jan Peveling-Oberhag, Claudia Doering, Andreas A. Schnitzbauer, Eva Herrmann, Stephan Zangos, Martin L. Hansmann, Christian Moench, Martin W. Welker, Stefan Zeuzem, Wolf O. Bechstein, Frank Ulrich. A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation. Transplant International 2016; 29(3): 369 doi: 10.1111/tri.12733
|
| 16 |
Motoyuki Otsuka, Takahiro Kishikawa, Takeshi Yoshikawa, Mari Yamagami, Motoko Ohno, Akemi Takata, Chikako Shibata, Rei Ishibashi, Kazuhiko Koike. MicroRNAs and liver disease. Journal of Human Genetics 2017; 62(1): 75 doi: 10.1038/jhg.2016.53
|
| 17 |
María Torres-Durán, José Luis Lopez-Campos, Miriam Barrecheguren, Marc Miravitlles, Beatriz Martinez-Delgado, Silvia Castillo, Amparo Escribano, Adolfo Baloira, María Mercedes Navarro-Garcia, Daniel Pellicer, Lucía Bañuls, María Magallón, Francisco Casas, Francisco Dasí. Alpha-1 antitrypsin deficiency: outstanding questions and future directions. Orphanet Journal of Rare Diseases 2018; 13(1) doi: 10.1186/s13023-018-0856-9
|
| 18 |
N. V. Palkina, A. V. Komina, M. B. Aksenenko, T. G. Ruksha. The pro-oncogenic effect of miR-106a microRNA inhibition in melanoma cells in vitro. Cell and Tissue Biology 2017; 11(1): 1 doi: 10.1134/S1990519X17010072
|
| 19 |
Yang An, Song Gao, Wen-Chao Zhao, Bao-An Qiu, Nian-Xin Xia, Peng-Jun Zhang, Zhen-Ping Fan. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(24): 2596-2604 doi: 10.3748/wjg.v24.i24.2596
|
| 20 |
Jing Li, Minling Lv, Qi Huang, Rui Hu, Xin Zhong, Xinfeng Sun, Wenxing Feng, Zhiyi Han, MengQing Ma, Wei Zhang, Xiaozhou Zhou. FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42560-w
|
| 21 |
S. V Tsyrenzhapova, E. Yu Sergeeva, M. B Aksenenko, N. V Palkina, A. V Komina, Tatiana G. Ruksha. DECREASE OF MIGRATION ACTIVITY AND PROLIFERATION OF BRO MELANOMA CELLS BY MIR-4286 INHIBITION. Russian Journal of Skin and Venereal Diseases 2017; 20(4): 196 doi: 10.18821/1560-9588-2017-20-4-196-200
|
| 22 |
Yingjie Zheng, Jingyu Zhang, Bin Ye. miR‐138 mediates sorafenib‐induced cell survival and is associated with poor prognosis in cholangiocarcinoma cells. Clinical and Experimental Pharmacology and Physiology 2020; 47(3): 459 doi: 10.1111/1440-1681.13205
|
| 23 |
Ioannis A. Ziogas, Georgios Sioutas, Konstantinos S. Mylonas, Georgios Tsoulfas. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. MicroRNA 2019; 9(1): 25 doi: 10.2174/2211536608666190619155406
|
| 24 |
Xiao-Ran Long, Yao-Jun Zhang, Mei-Yin Zhang, Keng Chen, X.F Steven Zheng, Hui-Yun Wang. Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases. Aging 2017; 9(6): 1565 doi: 10.18632/aging.101253
|
| 25 |
Valeria Abbate, Margherita Marcantoni, Felice Giuliante, Fabio Vecchio, Ilaria Gatto, Caterina Mele, Antonio Saviano, Damiano Arciuolo, Eleonora Gaetani, Maria Ferrari, Igor Giarretta, Francesco Ardito, Laura Riccardi, Alberto Nicoletti, Francesca Ponziani, Antonio Gasbarrini, Maurizio Pompili, Roberto Pola. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. International Journal of Molecular Sciences 2017; 18(5): 1043 doi: 10.3390/ijms18051043
|
| 26 |
Karina Bezerra Salomão, Julia Alejandra Pezuk, Graziella Ribeiro de Souza, Pablo Chagas, Tiago Campos Pereira, Elvis Terci Valera, María Sol Brassesco. MicroRNA dysregulation interplay with childhood abdominal tumors. Cancer and Metastasis Reviews 2019; 38(4): 783 doi: 10.1007/s10555-019-09829-x
|
| 27 |
Diana Gabriela Iacob, Adelina Rosca, Simona Maria Ruta. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World Journal of Gastroenterology 2020; 26(11): 1113-1127 doi: 10.3748/wjg.v26.i11.1113
|
| 28 |
Soon Sun Kim, Ji Sun Nam, Hyo Jung Cho, Je Hwan Won, Jin Woo Kim, Jae‐Hoon Ji, Min Jae Yang, Joo Han Park, Choong‐Kyun Noh, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong. Plasma micoRNA‐122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2017; 32(1): 199 doi: 10.1111/jgh.13448
|
| 29 |
Xue-Min Wu, Zhi-Feng Xi, Pinhu Liao, Hong-Dong Huang, Xiao-Ying Huang, Chao Wang, Yun Ma, Qiang Xia, Jin-Guang Yao, Xi-Dai Long. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1. Oncotarget 2017; 8(46): 81235 doi: 10.18632/oncotarget.16027
|
| 30 |
Abdul Malik, Prajjalendra Barooah, Snigdha Saikia, Subhash Medhi, Simanta Kalita, Manash Jyoti Kalita, Partha Pratim Das, Kalpajit Dutta, Pooja Bharali, Manash Pratim Sarma, Preeti Sarma, Mallika Bhattacharyya, Premashis Kar, Bhabadev Goswami, Musaed Alkholief, Aws Alshamsan. Circulating MicroRNA-122 as a Potential Biomarker for Hepatitis C Virus Induced Hepatocellular Carcinoma. International Journal of Cancer Management 2022; 15(11) doi: 10.5812/ijcm-131221
|
| 31 |
Suthee Rapisuwon, Eveline E. Vietsch, Anton Wellstein. Circulating biomarkers to monitor cancer progression and treatment. Computational and Structural Biotechnology Journal 2016; 14: 211 doi: 10.1016/j.csbj.2016.05.004
|
| 32 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 33 |
Leila Gorgani, Maedeh Mohammadi, Ghasem Najafpour Darzi, Jahan Bakhsh Raoof. Metal-organic framework (MOF)-based biosensors for miRNA detection. Talanta 2024; 273: 125854 doi: 10.1016/j.talanta.2024.125854
|
| 34 |
Sijia Shen, Yuxin Lin, Xuye Yuan, Li Shen, Jiajia Chen, Luonan Chen, Lei Qin, Bairong Shen. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Scientific Reports 2016; 6(1) doi: 10.1038/srep38311
|
| 35 |
Claudia Tito, Elena De Falco, Paolo Rosa, Alessia Iaiza, Francesco Fazi, Vincenzo Petrozza, Antonella Calogero. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes 2021; 12(8): 1154 doi: 10.3390/genes12081154
|
| 36 |
Cheng-Zuo Xiao, Wei Wei, Zhi-Xing Guo, Mei-Yin Zhang, Yong-Fa Zhang, Jia-Hong Wang, Ming Shi, Hui-Yun Wang, Rong-Ping Guo. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Journal of Cancer Research and Clinical Oncology 2017; 143(2): 263 doi: 10.1007/s00432-016-2280-7
|
| 37 |
Hu Liang, Ji Ai-Jun, Zhang Ji-Zong, Han Jian-Bo, Zhao Liang, Yi Yong-Xiang, Yu Chen. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma. Anti-Cancer Drugs 2019; 30(2): 186 doi: 10.1097/CAD.0000000000000711
|
| 38 |
Dragos Cretoiu, Jiahong Xu, Junjie Xiao, Nicolae Suciu, Sanda Maria Cretoiu. Circulating MicroRNAs as Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/3851054
|
| 39 |
Xin Li, Chuanyun Li, Liping Zhang, Min Wu, Ke Cao, Feifei Jiang, Dexi Chen, Ning Li, Weihua Li. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-019-1085-0
|
| 40 |
Maryam Koopaie, Mahnaz Fatahzadeh, Sajad Kolahdooz, Reza Mousavi. A Review of Salivary Biomarkers in Breast Cancer. Current Women s Health Reviews 2023; 19(2) doi: 10.2174/1573404818666220512152015
|
| 41 |
Junhao Lu, Licheng Tang, Yuqiang Xu, Kuikui Ge, Jinjiang Huang, Meigang Gu, Jiang Zhong, Qingshan Huang. Mir‐1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3. Journal of Cellular Biochemistry 2018; 119(11): 9229 doi: 10.1002/jcb.27190
|
| 42 |
Shuping Qu, Qiuyuan Shi, Jing Xu, Wanwan Yi, Hengwei Fan. Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma. Evolutionary Bioinformatics 2020; 16 doi: 10.1177/1176934320920562
|
| 43 |
Xiaoqin Du, Wanhu Fan, Yunru Chen. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Gene 2018; 657: 30 doi: 10.1016/j.gene.2018.03.003
|
| 44 |
Ke Li, Qi Zhang, Duan Niu, Hailong Xing, Tao Huang. Mining miRNAs’ Expressions in Glioma Based on GEO Database and Their Effects on Biological Functions. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5637864
|
| 45 |
Renata Sisto, Pasquale Capone, Luigi Cerini, Filippo Sanjust, Enrico Paci, Daniela Pigini, Maria Pia Gatto, Monica Gherardi, Andrea Gordiani, Nunziata L’Episcopo, Giovanna Tranfo, Pieranna Chiarella. Circulating microRNAs as potential biomarkers of occupational exposure to low dose organic solvents. Toxicology Reports 2019; 6: 126 doi: 10.1016/j.toxrep.2019.01.001
|
| 46 |
Rajeev Chandel, Roli Saxena, Ashim Das, Jyotdeep Kaur. Association of rno‐miR‐183‐96‐182 cluster with diethyinitrosamine induced liver fibrosis in Wistar rats. Journal of Cellular Biochemistry 2018; 119(5): 4072 doi: 10.1002/jcb.26583
|
| 47 |
Lucia Natarelli, Fabio Virgili, Christian Weber. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. International Journal of Molecular Sciences 2021; 22(22): 12243 doi: 10.3390/ijms222212243
|
| 48 |
Jing Yang, Na Lin, Miaomiao Niu, Boshu Yin. Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring. Aging 2024; 16(14): 11460 doi: 10.18632/aging.205980
|
| 49 |
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.72276
|
| 50 |
Mengxuan Lu, Xia Kong, Huaigao Wang, Guoliang Huang, Caiguo Ye, Zhiwei He. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget 2017; 8(5): 8775 doi: 10.18632/oncotarget.14452
|
| 51 |
Ilaria Chiodi, A. Ivana Scovassi, Chiara Mondello. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer. 2017; : 607 doi: 10.1002/9781119023647.ch16
|
| 52 |
Cun-qing Kong, Xing-cai Chen, Guan-hua Qiu, Jing-chen Liang, Duo Wang, Xin-yu Liu, Jun-jie Liu, Yao-qi Han, Xiao-hui Fan, Maciej Gagat. Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell Line. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6638915
|
| 53 |
Sidika Genc, Tarik Yagci, Dimitra P. Vageli, Riza Dundar, Panagiotis G. Doukas, Sotirios G. Doukas, Maria Tolia, Nikolaos Chatzakis, Aristidis Tsatsakis, Ali Taghizadehghalehjoughi. Exosomal MicroRNA-223, MicroRNA-146, and MicroRNA-21 Profiles and Biochemical Changes in Laryngeal Cancer. ACS Pharmacology & Translational Science 2023; 6(5): 820 doi: 10.1021/acsptsci.3c00038
|
| 54 |
Hao Wang, Jiamao Luo, Chun Liu, Huilin Niu, Jing Wang, Qi Liu, Zhongming Zhao, Hua Xu, Yanqing Ding, Jingchun Sun, Qingling Zhang. Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer. BMC Bioinformatics 2017; 18(1) doi: 10.1186/s12859-017-1796-4
|
| 55 |
Jinghang Xu, Ping An, Cheryl A. Winkler, Yanyan Yu. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01271
|
| 56 |
XIAOHU HE, WEIJIA LIAO, YULAN LI, YONGQIN WANG, QIAN CHEN, JUNFEI JIN, SONGQING HE. Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival. Oncology Letters 2015; 10(6): 3639 doi: 10.3892/ol.2015.3773
|
| 57 |
Feng Wang, Jun Wang, Linlin Ju, Lin Chen, Weihua Cai, Jialin Yang. Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(5): 576 doi: 10.1177/0004563218755815
|
| 58 |
Manal S. Fawzy, Eman A. Toraih. MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma. Precision Medical Sciences 2021; 10(1): 4 doi: 10.1002/prm2.12031
|
| 59 |
Fenglin Wang, Min Dai, Hongjie Chen, Yue Li, Jiongshan Zhang, Zengcheng Zou, Hongzhi Yang. Prognostic value of hsa‑mir‑299 and hsa‑mir‑7706 in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8710
|